Abstract
The fundamental role of the inflammatory activation in the pathophysiology of atherosclerosis is now widely established. Different strategies for positive modulation of these processes have been proposed, but the clinical results have been contradictory and sometimes, due to safety issues, a specific therapeutic approach has been withdrawn before reaching the final acceptation of the regulatory agencies. The reasons for these negative conclusions can be multiple and not always completely clarified. In addition it is frequently difficult to separate the metabolic or cardiovascular effects of these approaches (i.e., hypocholesterolemic, hypoglycemic, hypotensive) from the real anti-inflammatory effects. The present review discusses the effects of different anti-inflammatory strategies developed in the last decade for the treatment of atherosclerosis, and consequently for the prevention of cardiovascular events. The complexity of the inflammatory network, well represented by the presence and the action of a plethora of cells and molecules, suggests a word of caution in the evaluation of the clinical results about significant improvements of the atherosclerotic burden: only randomized controlled trials with cardiovascular hard end points can give the final answer.
Keywords: Atherosclerosis, cardiovascular events, cardiovascular prevention, cholesterol, C-reactive protein, inflammation, metabolic or cardiovascular effects, hypocholesterolemic, hypoglycemic, hypotensive, anti-inflammatory effects, anti-inflammatory strategies, plethora of cells, atherosclerotic burden, with cardiovascular hard end points
Current Pharmaceutical Biotechnology
Title: Anti-Inflammatory Approaches to Reduce Acute Cardiovascular Events: Not Only Benefits
Volume: 13 Issue: 1
Author(s): Aldo Pende and Franco Dallegri
Affiliation:
Keywords: Atherosclerosis, cardiovascular events, cardiovascular prevention, cholesterol, C-reactive protein, inflammation, metabolic or cardiovascular effects, hypocholesterolemic, hypoglycemic, hypotensive, anti-inflammatory effects, anti-inflammatory strategies, plethora of cells, atherosclerotic burden, with cardiovascular hard end points
Abstract: The fundamental role of the inflammatory activation in the pathophysiology of atherosclerosis is now widely established. Different strategies for positive modulation of these processes have been proposed, but the clinical results have been contradictory and sometimes, due to safety issues, a specific therapeutic approach has been withdrawn before reaching the final acceptation of the regulatory agencies. The reasons for these negative conclusions can be multiple and not always completely clarified. In addition it is frequently difficult to separate the metabolic or cardiovascular effects of these approaches (i.e., hypocholesterolemic, hypoglycemic, hypotensive) from the real anti-inflammatory effects. The present review discusses the effects of different anti-inflammatory strategies developed in the last decade for the treatment of atherosclerosis, and consequently for the prevention of cardiovascular events. The complexity of the inflammatory network, well represented by the presence and the action of a plethora of cells and molecules, suggests a word of caution in the evaluation of the clinical results about significant improvements of the atherosclerotic burden: only randomized controlled trials with cardiovascular hard end points can give the final answer.
Export Options
About this article
Cite this article as:
Pende Aldo and Dallegri Franco, Anti-Inflammatory Approaches to Reduce Acute Cardiovascular Events: Not Only Benefits, Current Pharmaceutical Biotechnology 2012; 13 (1) . https://dx.doi.org/10.2174/138920112798868539
DOI https://dx.doi.org/10.2174/138920112798868539 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |
Call for Papers in Thematic Issues
Artificial Intelligence in Bioinformatics
Bioinformatics is an interdisciplinary field that analyzes and explores biological data. This field combines biology and information system. Artificial Intelligence (AI) has attracted great attention as it tries to replicate human intelligence. It has become common technology for analyzing and solving complex data and problems and encompasses sub-fields of machine ...read more
Latest Advancements in Biotherapeutics
The scope of this thematic issue is to comprehensively explore the rapidly evolving landscape of biotherapeutics, emphasizing breakthroughs in precision medicine. Encompassing diverse therapeutic modalities, the issue will delve into the latest developments in monoclonal antibodies, CRISPR/Cas gene editing, CAR-T cell therapies, and innovative drug delivery systems, such as nanoparticle-based ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Association of Wheat Allergy and Coeliac Disease through Pediatric and Adult Age: A Review of Literature
Current Nutrition & Food Science Emerging Synergisms Between Drugs and Physiologically-Patterned Weak Magnetic Fields: Implications for Neuropharmacology and the Human Population in the Twenty-First Century
Current Neuropharmacology Management of the Low Cardiac Output Syndrome Following Surgery for Congenital Heart Disease
Current Cardiology Reviews Human Ascariasis: An Updated Review
Recent Patents on Inflammation & Allergy Drug Discovery Psoriatic Arthritis and its Novel Therapeutics
Current Rheumatology Reviews Artificial Blood: A Futuristic Dimension of Modern Day Transfusion Sciences
Cardiovascular & Hematological Agents in Medicinal Chemistry New Antipsychotics and Schizophrenia: A Review on Efficacy and Side Effects
Current Medicinal Chemistry Invasive Aspergillosis: New Insights into Disease, Diagnostic and Treatment
Current Pharmaceutical Design Current Research on Opioid Receptor Function
Current Drug Targets Role of Adiponectin in Obesity, Hypertension, and Metabolic Syndrome
Current Hypertension Reviews Under-Dosing of Etomidate for Rapid Sequence Intubation in the Emergency Department
Current Drug Safety C5a, a Therapeutic Target in Sepsis
Recent Patents on Anti-Infective Drug Discovery Epidural Analgesia in the Post-Anaesthesia Care Unit
Current Drug Targets Patent Perspective for Potential Antioxidant Compounds-Rutin and Quercetin
Recent Patents on Nanomedicine Mood Disorders in Elderly Population: Neurostimulative Treatment Possibilities
Recent Patents on CNS Drug Discovery (Discontinued) Revisiting Antipsychotic-induced Akathisia: Current Issues and Prospective Challenges
Current Neuropharmacology Characterization and Antihypertensive Effect of the Complex of (-)-β- pinene in β-cyclodextrin
Current Pharmaceutical Biotechnology Analgesic Efficacy and Safety of Spinal Oxycodone in Total Hip Arthroplasty: A Preliminary Study
Current Medicinal Chemistry Nitric Oxide Mimetic Molecules as Therapeutic Agents in Alzheimers Disease
Current Alzheimer Research Safety of Inhaled Corticosteroids. Why the Variation in Systemic Adverse Effects?
Current Pediatric Reviews